News Focus
News Focus
icon url

keekee

06/24/20 2:09 PM

#324 RE: keekee #323

So, why the continued sell-off??? Well, if you are a market maker of AFH and AIKI and bent on profiling and using people's private information for a vendetta, yo see no reason and hardly read between the lines. You just short...and short and short until, as now, it is evident that you are a DUMB FOOL!
icon url

Fullpower7

06/25/20 10:20 PM

#328 RE: keekee #323

Keekee, thanks for the updates.
Shouldn't we be seeing at some point a bounce back?
icon url

XenaLives

10/08/20 10:20 AM

#441 RE: keekee #323

Repeating your post - this is interesting.

PCR tests are unreliable, antibody tests tell more, but they are discoraged?

You seem to know a lot about this stock keekee, let's get a discussion on the fundamentals going.

So, THE FDA DID NOT STOP Rapid DPP COVID-19 tests. The FDA merely revoked EAuth. Now read what I will post below....the FDA three days go just out saying Healthcare Providers should continue using these tesk systems, but just be aware of its limitations. Read below: CAUTION...I AM LOADED HUGE!

"The FDA is not aware of an antibody test that has been validated for diagnosis of SARS-CoV-2 infection. While the FDA remains open to receiving submissions for these tests for such uses, based on the underlying scientific principles of antibody tests, the FDA does not expect that an antibody test can be shown to definitively diagnose or exclude SARS-CoV-2 infection.

Recommendations
The FDA recommends health care providers:

Continue to use serological (antibody) tests, as appropriate, and be aware of their limitations.
Do not use serological (antibody) tests as the sole basis to diagnose COVID-19 but instead as information about whether a person may have been exposed.
Be aware that not all marketed serological tests have been evaluated by the FDA. The FDA’s authorized tests, including serological tests, are listed on the Emergency Use Authorization (EUA) page. Tests being offered under a policy outlined in the FDA’s COVID-19 Diagnostic Policy Guidance are listed on our FAQ page. Such tests have not been reviewed by the FDA, unless an EUA has also been submitted and reviewed by FDA."

https://www.fda.gov/medical-devices/letters-health-care-providers/important-information-use-serological-antibody-tests-covid-19-letter-health-care-providers